Author Details :
Volume : 6, Issue : 3, Year : 2021
Article Page : 108-116
Alzheimer’s disease is that the most common cause of dementia in older, individuals and a major public health concern. The goal of this critical evaluation is to provide a short overview of Alzheimer’s disease. The study concentrates on the biochemical aspects of AD and MCI. It is the fourth most common cause of mortality in the United States, and it is spreading to other nations. With Alzheimer's disease, the total size of the brain decreases as the tissue loses nerve cells and connections. The loss of brain cells that occurs as a result of insanity cannot be stopped or reversed. The set up's aims include measurements for gift interventions in addition to an aim to improve research on interference and therapy. Although there are no disease-modifying medications available for Alzheimer's disease, certain options may help to reduce symptoms and enhance quality of life, therefore assisting patients to some extent. In addition, the paper discusses current attempts to create innovative treatments and improvements in the use of biomarkers for diagnosing SD.
Keywords: Alzheimer's disease, Dementia, Pathology, Causation, Neurodegeneration, Therapy, and
How to cite : Sharma S, Alzheimer’s disease: Causes, treatment & basic science review. IP Int J Compr Adv Pharmacol 2021;6(3):108-116
Copyright © 2021 by author(s) and IP Int J Compr Adv Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (creativecommons.org)